More than 175 companies adopt Vault QMS to streamline end-to-end
quality processes
BARCELONA, Spain, May 12, 2021 /PRNewswire/ -- Leading
companies continue to prioritize the modernization of quality
management. With this shift well underway, six of the top 20 global
pharmaceutical companies have partnered with Veeva Systems (NYSE:
VEEV) to standardize on Veeva Vault QMS for greater efficiency and
better visibility across the enterprise. A growing number of
organizations, including more than 175 biopharma, contract
manufacturers, generics, and medtech companies, have adopted Vault
QMS to streamline and automate quality processes.
"As a long-standing partner, Veeva has been collaborating
closely with us on our digital quality initiatives," said Nicolás
Maldonado, senior director, quality policies and systems at Gilead
Sciences. "We are excited to bring in Veeva Vault QMS to simplify,
harmonize, and automate quality processes across multiple strategic
businesses within Gilead."
More organizations are adopting Veeva's modern cloud solutions
to bring together quality processes for greater transparency and
real-time visibility across global sites, manufacturing partners,
and suppliers. Industry leaders are partnering with Veeva to
simplify quality management and increase operational efficiency
with a unified quality platform.
"Companies want a trusted partner that remains focused on
customer success for digital quality transformation," said
Mike Jovanis, vice president, Veeva
Vault Quality. "Veeva is committed and will continue to deliver
customer-focused innovation across product development and
manufacturing."
Veeva's continuous innovation is helping customers proactively
manage quality and increase agility. Over the last year, new
features for Vault QMS include:
- Seamless connection between Vault QMS and Veeva Vault
Registrations to reduce cycle time and increase transparency within
post-market change control
- Quality Risk Management (QRM) advancements, including FMEA
methodology to support proactive identification and mitigation of
risks
- Fully automated process for external auditees such as CMOs and
suppliers to respond to audit findings directly within the
system
Vault QMS is part of the Veeva Vault Quality Suite, including
Veeva Vault QualityDocs, Veeva Vault Training, Veeva Vault Station
Manager, and Veeva Vault Product Surveillance to automate and
harmonize quality processes globally.
In other news today, Veeva announced that Bluepharma selected
Vault Quality Suite to unify global quality management. Read the
press release for more information.
Learn more about Vault Quality Suite at the upcoming Veeva
R&D and Quality Summit Connect Europe, 20 May 2021. The online event is open to life
sciences industry professionals. Register and stay up to date on
program details at veeva.com/Summit.
Additional Information
For more on Veeva Vault QMS,
visit: veeva.com/QMS
Connect with Veeva on LinkedIn:
linkedin.com/company/veeva-systems
Follow @veeva_eu on Twitter: twitter.com/veeva_eu
About Veeva Systems
Veeva is the global leader in
cloud software for the life sciences industry. Committed to
innovation, product excellence, and customer
success, Veeva serves more than 975 customers, ranging
from the world's largest pharmaceutical companies to emerging
biotechs. As a Public Benefit Corporation, Veeva is committed to
balancing the interests of all stakeholders, including
customers, employees, shareholders, and the industries
it serves. For more information, visit veeva.com/eu.
Forward-looking Statements
This release contains
forward-looking statements, including the market demand for and
acceptance of Veeva's products and services, the results from use
of Veeva's products and services, and general business conditions
(including the on-going impact of COVID-19), particularly within
the life sciences industry. Any forward-looking statements
contained in this press release are based upon Veeva's historical
performance and its current plans, estimates, and expectations, and
are not a representation that such plans, estimates, or
expectations will be achieved. These forward-looking statements
represent Veeva's expectations as of the date of this press
announcement. Subsequent events may cause these expectations to
change, and Veeva disclaims any obligation to update the
forward-looking statements in the future. These forward-looking
statements are subject to known and unknown risks and uncertainties
that may cause actual results to differ materially. Additional
risks and uncertainties that could affect Veeva's financial results
are included under the captions, "Risk Factors" and "Management's
Discussion and Analysis of Financial Condition and Results of
Operations," in the company's filing on Form 10-K for the period
ended January 31, 2021. This is available on the
company's website at veeva.com under the Investors
section and on the SEC's website at sec.gov. Further
information on potential risks that could affect actual results
will be included in other filings Veeva makes with the SEC from
time to time.
Contact:
|
|
Deivis
Mercado
Veeva
Systems
925-226-8821
deivis.mercado@veeva.com
|
|
Logo -
https://mma.prnewswire.com/media/1488285/Veeva_Systems_Logo.jpg